January, 2023          


13 biotech companies to discover in the Swiss Health Valley in 2023


By Jim Cornall, in

July, 2022          


Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study


By Einar Stefansson et al. Published by Acta Ophthalmologica

July, 2022          


Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease


By Lee Shettle et al., Published by Clinical Ophthalmology

April, 2022          


2023 Will Be Pivotal Year for Oculis’ Potentially Transformative Medicines


By Gail Dutton in Biospace

December, 2021


The Diabetic Eye Disease Pipeline in 2021


By Xuejing Chen, Arshad M. Khanani and Caroline R. Baumal, in Retina Today


December, 2021          


Topical drug delivery to the retina: obstacles and routes to success


By Thorsteinn Loftsson, published by Expert Opinion on Drug Delivery

May, 2021


Ocular Surface Disease Product Roundup: The players you need to know


Editorial Spotlight (several authors) on CRST – Cataract and Refractive Surgery Today

April, 2021


Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment


By Thorsteinn Loftsson and Einar Stefansson, published by Acta Ophthalmologica

April, 2021


The quest for topical treatments for the posterior segment


By Dr Ramin Tadayoni on Ophthalmology Times Europe